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Abstract 
 
Background: 
Neuromuscular Scoliosis is a frequent complication of Cerebral Palsy that requires surgical 
management including spinal fusion. The objective of this observational study was to describe 
differences in the frequency of postoperative complications in children with Cerebral Palsy 
following spinal fusion surgery compared to children with Idiopathic Scoliosis. 
 
Methods:  
The 2016 Kids’ Inpatient Database was queried to identify pediatric patients (<21 years old) with 
concurrent diagnoses of Cerebral Palsy and Neuromuscular Scoliosis undergoing spinal fusion 
surgery. Cases were compared to children without Cerebral Palsy and with a diagnosis of 
Idiopathic Scoliosis undergoing the same procedure. Fitted Poisson regression analysis with robust 
variance was performed to estimate relative risks in the frequency of various clinical complications 
while adjusting for several potentially confounding variables of importance.  
 
Results: 
A total of 660 cases and 5,244 comparators were identified. Compared to children with Idiopathic 
Scoliosis, children with Cerebral Palsy were younger (13.6 vs. 14.3 years), more likely to be male 
(54% vs. 23%), and more likely to have had governmental insurance (52% vs. 32%). They also 
had longer hospital lengths of stay (8 days vs. 4 days). After adjusting for a number of potentially 
confounding sociodemographic and clinical variables, children with Cerebral Palsy were more 
5 
likely to have postoperative pulmonary, gastrointestinal,  and surgical complications, receive blood 
transfusions, and be admitted to the ICU.  
 
Conclusions: 
Children with Cerebral Palsy have an increased risk of complications following spinal fusion 
surgery leading to longer hospital stays. These results further inform surgical decision-making and 
anticipatory guidance for these children and their caregivers.   
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Chapter 1: Introduction  
Cerebral Palsy and Neuromuscular Scoliosis  
Cerebral Palsy (CP) is a group of disorders that affect movement, muscle tone, and posture 
secondary to lesions or anomalies of the brain arising in the early stages of development [1]. It is 
one of the most common physical and developmental disabilities in childhood, with a prevalence 
of 3 per 1,000 births [1-3]. The condition presents when a child fails to reach their motor milestones 
and when they show qualitative differences in motor development such as asymmetric motor 
function or  unusual stiffness or floppiness [2].   
When the motor impairment affects the trunk, Neuromuscular Scoliosis (NMS) often 
develops. NMS typically presents before the age of 10 years, is rapidly progressive, and tends to 
progress even after skeletal maturity [4-7]. This condition  is associated with several systemic and 
chronic illnesses of which CP is the leading cause. The prevalence of NMS in children with CP 
ranges from 38% to 64% and is directly related to the severity of neurological impairment [4, 5, 8, 
9]. The spinal deformity seen in children with CP as a result of NMS often leads to pelvic obliquity, 
which adversely affects seating and posture [5, 10] and increases the risk for decubitus ulcers, 
thoracic-pelvic impingement and pain, and restrictive lung disease [4]. Non-surgical interventions, 
including the use of physical therapy and orthotic braces, are often unsuccessful in controlling the 
progression of NMS and surgical correction is often necessary [11].  
 
Idiopathic Scoliosis  
Idiopathic Scoliosis (IS), the most common type of scoliosis with a prevalence ranging from  
0.47% to 5.2%, typically occurs in otherwise healthy adolescents and often develops when children 
are older than 10 years [11, 12]. This condition typically presents with uneven shoulders, waist 
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line asymmetry, or a rib prominence and is usually first identified by the patient, family member, 
general practitioner, or a school nurse [12]. The diagnosis of IS is one of exclusion and is made 
only when other syndromes have been ruled out. There is no single cause of IS and the current 
view is that it is a multifactorial disease with predisposing genetic factors [13, 14]. 
Scoliosis curve progression increases at the time of the adolescent growth spurt and 
markedly slows or ceases at the time of completion of growth; however, rates of curve progression 
in children with IS are usually slow overall [12].  
The management of IS often begins with physical therapy and orthotic braces.  When non-
operative interventions fail, however, surgical correction is often indicated [15]. In general, curves 
greater than 45 degrees should be treated surgically and surgery is performed in approximately 
10% of adolescents diagnosed with IS [12, 16].  
The goals of surgical stabilization for both NMS and IS are similar and are intended to 
achieve maximum permanent correction of the deformity, improve appearance by balancing the 
trunk, and improve the child’s level of function, respiratory status, pain, and quality of life while 
preventing progression of the curvature [13, 17].  
 
Overview of the Kids’ Inpatient Database (KID) 
The KID is the largest publicly available administrative all-payer national sampling of pediatric (≤ 
21 years of age) inpatient discharges and is managed as part of the Healthcare Cost and Utilization 
Project (HCUP) by the Agency for Healthcare Research and Quality (AHRQ) [18]. The KID is 
published on a triennial interval and includes data from non-federal hospitals, short-term stay 
hospitals, academic medical centers, and specialty hospitals. Hospitals not included in the dataset 
are federal hospitals, rehabilitation hospitals, psychiatric hospitals, or substance treatment centers.  
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The 2016 iteration is the most recent available data and includes information from more than 4,200 
hospitals and 6 million weighted discharges across 47 states designed to be representative of 
pediatric hospital care in the United States. The KID represents a sample of approximately 80% of 
all annual pediatric discharges.  
 The KID contains over 100 sociodemographic and clinical variables and utilizes the 
International Classification of Diseases, Tenth Revision (ICD-10) classification system of 
diagnoses and procedures. It also includes variables regarding payer status, geographic region, 
hospital charges, length of stay, and hospital characteristics including size and teaching status 
(Figure 1). The observational unit of the KID is at the level of facility discharges and does not 
enable prospective tracking of patients across repeat encounters.  
 
Specific Aims  
The primary aim of this large observational study was to describe differences in the frequency of 
several postoperative complications in children with and without CP following spinal fusion 
surgery. We utilized the 2016 KID to examine these endpoints among children and young adults 
(<21 years) who had a diagnosis of CP. We hypothesized that children with CP who had spinal 
fusion surgery would have longer and more costly hospitalizations, and experience more 
postoperative clinical complications, than children with IS.  
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Chapter 2: Methods  
Data Source 
A cross-sectional analysis was performed using the 2016 KID.  
 
Selection of Study Population 
Using International Classification of Diseases, Tenth Revision (ICD-10) diagnosis codes, all 
patients with CP (G80.0-G80.9) and a concurrent diagnosis of NMS (M41.40-M41.47) were 
identified in either the primary or any of the secondary discharge diagnoses (case population). To 
be included in the present study, patients had to have undergone spinal fusion surgery within 3 
days of admission. Cases due to trauma, with an additional diagnosis of IS, and who were missing 
data on critical variables such as age, gender, race, primary payer, total hospital charges, median 
income by ZIP code, or mortality were excluded. Spinal fusion surgery was limited to those 
performed via a posterior approach on the thoracic or lumber spine with fusion of greater than 1 
vertebra (see Appendix A for specific codes). We chose to focus on the posterior approach since 
it is the most common approach for this surgery and because there are substantial anatomic 
differences in anterior approaches that may confound results.  
All patients with a diagnosis of IS (M41.112-M41.27), without CP or NMS, who 
underwent spinal fusion surgery within 3 days of admission, were not admitted due to trauma, and 
who were not missing data on critical variables were identified and served as our comparison 
group.  
Overall, 15% of cases and 12% of comparators (p-value: 0.27) were excluded, and the main 
reasons for exclusion were due to missing data on race (10% of cases, 9% of comparators, p-value: 
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0.76) and admissions due to trauma (5% of cases, 3% of comparators, p-value: 0.15). One 
additional case was excluded due to an exceedingly long hospital length of stay (LOS) of 162 days. 
 
Independent and Dependent Variables  
Patient and hospital variables assessed included patient age, gender, race (white, black, Hispanic, 
other; defined as Asian Pacific, Native American, or unknown), payer (private, government; 
defined as Medicaid or Medicare, and other; defined as self-pay, no charge, or unknown), total 
hospital charges, median income quartile by ZIP code, and hospital LOS. Age was assessed both 
continuously and categorically via six age-groups, defined by the National Institute of Child Health 
and Human Development (NICHD): infant (<1 year), toddler (1-2 years), early childhood (3-5 
years), middle childhood (6-11 years), early adolescence (12-18 years), and late adolescence (19+ 
years) [19].  The patient setting was defined as either urban-teaching hospital (central and fringe 
counties of ≥1 million population), urban-nonteaching hospital (counties in metro areas of 250k- 
<1 million and counties 50k - <250k) or rural hospital (micropolitan or non-core counties). We 
defined four hospital regions consistent with the U.S. Census Bureau geographic definitions (East, 
South, Midwest, West) [20].  
 We examined a variety of postoperative complications using a modified definition of 
morbidity that has been used in other pediatric studies using the KID [21-25]. These complications 
broadly include infections, surgical complications, mechanical wounds, as well as pulmonary and 
gastrointestinal related complications. We identified procedures frequently associated with spinal 
surgery including autologous and donor blood transfusions and compared differences between our 
respective comparison groups in terms of ICU admission characteristics, using ICD-10 diagnosis 
and procedure surrogates, including arterial line placement, ventilator use, and central line 
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placement. The specific postoperative complications that comprise each category and their 
corresponding ICD-10 codes are found in Appendix B.   
 
Statistical Analysis  
We examined differences in the distribution of categorical variables, using chi-square tests, and 
Student’s t-test for continuous variables, between children with CP and those without CP 
undergoing spinal fusion surgery. All statistical tests were two-sided with statistical significance 
considered as a p-value <0.05. The data were weighted, using HCUP-provided weights, to be 
representative of all U.S. inpatient discharges using the STATA svy function. A Fitted Poisson 
regression analysis with robust variance was performed simultaneously adjusting for age, gender, 
race, insurance payer, and common comorbidities associated with CP (gastroesophageal reflux 
disease, failure to thrive, nutritional deficiency, gastrostomy tube, tracheostomy tube), for 
purposes of estimating relative risks of certain patient morbidities between children with and 
without CP. For stratum with single sampling units, the average of the variances from the strata 
with multiple sampling units was used to calculate variance estimates. All statistical analyses for 
this study were performed in STATA 16.0 statistical software (Stata Corps. 2019. College Station, 
TX).  
 
Ethical Considerations  
The Institutional Review Board at the University of Massachusetts Medical School deemed this 
study exempt from IRB review due to the de-identified nature of the data. In compliance with the 
KID data use agreement, this study does not report information where the number of observations 
is less than or equal to 10.  
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Chapter 3: Results  
Patient and Hospital Characteristics  
We identified a total of 660 cases with CP and 5,244 comparators with IS who underwent spinal 
fusion surgery. Compared with children undergoing spinal fusion surgery for IS, children with CP 
were more likely to be younger and to be male (Table 1). Children with CP were more likely to be 
in the Middle Childhood age group while children with IS were more likely to undergo surgery 
during their Early Adolescent years (Table 1). Children with CP were more likely to have 
governmental health insurance while those with IS were more likely to have private insurance 
(Table 1).   
Approximately 62% of the surgeries were performed in large hospitals and the vast majority 
of surgeries were performed at urban teaching hospitals. Spinal surgeries were performed 
throughout the United States with minimal regional variation (Table 1).   
 
Hospital Course in Children with CP Undergoing Spinal Fusion Surgery  
The overall complication rate for children with CP was 44%, which is approximately double the 
rate when compared to children with IS (Table 2). The majority of complications were due to the 
need for blood transfusions (30%). Slightly more than 10% of complications were due to 
pulmonary complications, including postoperative pulmonary insufficiency and postoperative 
pneumothorax. Approximately 6% of complications were due to gastrointestinal complications 
such as paralytic ileus and postoperative obstruction. There were also more surgical related 
complications, such as intraoperative hemorrhages and accidental punctures or lacerations of 
nearby structures, in children with CP (3% vs. 0.5%) . Children with IS were more likely to have 
no postoperative complications while children with CP were more likely to have at least one or 
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two postoperative complications (Table 2). Approximately 15% of children with CP were admitted 
to the ICU postoperatively compared to 1% of children with IS (Table 2).  Children with CP had 
longer hospital lengths of stay and greater total charges than did children with IS (Table 1). 
 
Fitted Poisson Regression Analysis  
After adjusting for age, race, gender, insurance payer, and common comorbidities that influence 
the health of children with CP, those with CP had a greater than  70% increased risk of having any 
postoperative complication compared to children with IS (Table 3). Children with CP had 
approximately 8 times (95% CI: 2.9-20.7) the risk of experiencing pulmonary complications and 
more than 3 times (95% CI: 1.5-7.0) the risk of having gastrointestinal complications. They also 
had an almost 5 times (95% CI: 1.9-20.8) the risk of having surgical complications. With regards 
to the need for blood transfusions, children with CP had more than a 50% increased risk compared 
to those with IS. They also had more than 6 times (95% CI: 1.1-2.2) the risk of being admitted to 
the ICU.  
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Chapter 4: Discussion  
To our knowledge, this is the largest and most recent study to date analyzing spinal fusion surgery 
in pediatric patients with CP. We used a national sample of pediatric hospital discharges to describe 
differences in the frequency of complications and in-hospital outcomes between children with CP 
and those with IS following spinal fusion surgery. We found that following spinal fusion surgery, 
children with CP would have longer and more costly hospitalizations, and experience more 
pulmonary, gastrointestinal, or surgical complications, need a blood transfusion, or require 
admission to the ICU compared to children undergoing spinal fusion surgery for IS.  
 
Pulmonary Complications Following Spinal Fusion Surgery in Children with CP  
Similar to the results of previous studies that have examined the frequency of complications in 
children with NMS who underwent corrective surgery, our study supports the findings that 
pulmonary complications were among the most frequently occurring major complications after 
spinal surgery in this population [10, 11, 26, 27].  
Pulmonary dysfunction is a common complication of neuromuscular disorders such as CP, 
secondary to factors including  poor airway tone, recurrent aspiration, and thoracic cage deformity 
[28]. Although correction of the spinal curvature attempts to relieve the physical stress on the lungs 
and delay declining pulmonary function, functional respiratory status might be adversely affected 
perioperatively by a combination of factors including, but not limited to, poor pain control, 
atelectasis, and an inability to participate in pulmonary toilet [27]. This study affirms the 
importance of expert pulmonary management and surveillance in the care of these patients. Other 
studies have shown that use of preoperative non-invasive ventilation to strengthen respiratory 
muscles is a safe and effective way to mitigate potential respiratory complications [28, 29]. 
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Additionally, a thorough examination of the child’s respiratory system, including pulmonary 
function tests and preoperative chest x-ray, may be important to guide both preoperative and 
perioperative planning.  
 
Gastrointestinal Complications Following Spinal Fusion Surgery in Children With CP 
Our study demonstrates that children with CP have more than three times the risk of developing 
postoperative gastrointestinal complications compared to children with IS. These results are 
similar to other studies that have shown increased rates of ileus, obstruction, and pancreatitis 
following orthopedic surgeries in children with CP [30-32].  
Gastrointestinal disorders, including dysphagia, gastroesophageal reflux disease (GERD), and 
reduced bowel motility are common in children with CP and up to 70% of patients with CP have 
a diagnosis of GERD [28, 31]. Additionally, children with CP also frequently have nutritional 
deficits. In our study, 40% of children with CP had a diagnosis of either GERD, failure to thrive, 
or nutritional deficiency. Furthermore, 46% of children with CP had a gastrostomy tube in place 
suggesting nutritional concerns. Poor nutritional status has been linked to worse postoperative 
outcomes and a higher rate of complications [7, 33]. Other risk factors for gastrointestinal 
complications include limited mobility, intraoperative positioning, and hypotensive anesthesia 
[32]. Postoperative patient monitoring for signs of gastric distention and decreased tolerance of 
feeds is necessary to identify the possible development of gastrointestinal related complications 
[31, 34]. 
 
Blood Transfusions Following Spinal Fusion Surgery in Children with CP  
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Our data support previous findings suggesting that postoperative blood loss in children with CP is 
greater compared to children with other diagnoses [35, 36]. In a prior multicenter study that 
examined risk factors for blood loss during spinal fusion surgery in 272 children with CP, coronal 
curve magnitude and unit rod constructs were the strongest predictors of high volume blood loss 
[36]. Since NMS is often more rapidly progressive than IS, children with CP may have greater 
degrees of curvature in their spine necessitating more extensive and an increased number of bony 
releases to achieve the same correction compared to children with IS. The increased number of 
bony releases required may result in greater blood loss. Additionally, valproic acid, an 
anticonvulsant medication frequently used in the treatment of seizure disorders in patients with 
CP, increases the risk of bleeding during surgery in children with neuromuscular disease who 
undergo spine surgery [37-39]. While the KID does not provide information on medication use, 
60% of children with CP had a diagnosis of epilepsy compared to 1% of children with IS. Other 
factors implicated in major blood loss in this population include poor nutritional status and a 
greater depletion of clotting factors during spinal fusion surgery [40, 41]. The causes of greater 
blood loss are likely multifactorial and preoperative planning measures should consider the use of 
strategies for decreasing blood loss such as nutritional optimization, thorough medication review, 
consult with the patient’s neurologist for potential adjustment of antiepileptics such as valproic 
acid prior to surgery, and preparation for safe replacement of red cells as well as fresh frozen 
plasma to replace clotting factor deficiencies perioperatively.  
 
ICU Admissions Following Spinal Fusion Surgery in Children with CP  
Our findings suggest that children with CP have more than 6 times the risk of being admitted to 
the ICU following spinal fusion surgery compared to children with IS. Most of the admissions to 
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the ICU in children with CP were due to the need for a ventilator. Notably, 10% of children with 
CP while only 0.1% of children with IS needed ventilator support. Differences in ICU admissions 
may also be the result of hospital practice or preoperative planning. Given the high risk of 
perioperative complications in this population, many care teams send all patients with CP directly 
to the ICU postoperatively [5]. Further research and data are needed to guide surgeons regarding 
which patients with CP would most benefit from postoperative ICU admission.   
 
Study Strengths and Limitations  
The major strength of this study was the size and national representativeness of the KID which 
consists of more than 4,200 participating hospitals and is larger than alternative data sources such 
as the Pediatric Health Information System or the American College of Surgeons National Surgical 
Quality Improvement Program – Pediatric. The use of this database enabled us to identify over 
600 children and adolescents who underwent this relatively uncommon surgery.  
There are several limitations associated with this study that need to be considered in its 
interpretation. The KID depends on ICD-10 codes to determine the presence of various diagnoses 
and procedures, and these ICD-10 codes are susceptible to misclassification or miscoding. 
However, this database has been used in multiple neurologic [11, 27, 33, 42, 43] and orthopedic 
[42, 44-47] studies and has been accepted as a nationally representative data set.  
The KID is not a longitudinal data set and, therefore, it is not possible to determine if one 
patient had multiple admissions for the same reason or to be able to track re-admissions. Although 
this possibility cannot be excluded, we assume that multiple admissions in a given year for the 
same operation is uncommon, particularly for an extensive and invasive procedure such as spinal 
fusion.  
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The KID does not contain indicators of function or severity of illness, thus we lacked data 
on the patient’s clinical presentation, physical examination findings, radiological evaluation, 
specific indications for surgery, as well as length of operation.  
Notably, we were unable to report the frequency of mechanical wounds, infections, urinary 
complications, cardiovascular complications, foreign body complications, decubitus ulcer, 
complications related to central venous catheters, or venous thromboembolism because the sample 
size was fewer than 10, which requires suppression by the HCUP due to concerns with  patient 
confidentiality.  
 
Future Areas of Research  
Further research designed to examine the risk of surgical complications associated with an anterior 
or combined anterior-posterior surgical approach is necessary in order to increase current 
knowledge and inform surgical techniques in this population. Additionally, further research 
designed to reduce the risk of surgical complications among children with CP is necessary to 
develop guidelines for caregivers, surgeons, and other providers on both the appropriateness of 
surgery given the potential risks and also expectations for outcomes. Once additional prospective 
and contemporary data are available regarding outcomes in this population, interventions could be 
developed to reduce the rates of postoperative complications. These interventions could include 
preoperative pulmonary function tests and nutritional optimization, and plan for perioperative 
repletion of fresh frozen plasma and red blood cells.  
  
23 
Chapter 5: Conclusions  
NMS in children with CP presents at a young age, is rapidly progressive, and often requires 
surgical correction. In the present study, we analyzed the 2016 KID to examine the frequency of 
several in-hospital complications for pediatric patients with CP undergoing spinal fusion surgery 
compared to pediatric patients with IS. Our analysis revealed that children with CP are more likely 
to be male, to be younger, and to be on government health insurance. They also require longer 
hospital stays that incur greater costs. Children with CP were at increased risk of pulmonary 
complications, gastrointestinal complications, surgical complications, needing a blood transfusion, 
and being admitted to the ICU. These results will help to inform preoperative care and surgical 
decision-making. They may guide discussions of informed consent, and conversations regarding 
anticipatory guidance for children and their caregivers. Given the increased morbidity associated 
with scoliosis surgery in children with CP, further research into the short and long-term outcomes 
of these patients remains needed and identification of potentially modifiable prognostic factors is 
important.   
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Tables  
Table 1: Characteristics of Children with CP vs. IS undergoing Spinal Fusion Surgery and Hospital 
Characteristics 
Table 1. Characteristics of Children with 
CP vs. IS undergoing Spinal Fusion and 
Hospital Characteristics  
 
 CP 
(n=660) 
n(%) 
IS 
(n=5,244) 
n(%) 
P-value 
Male  359 (54.4) 1,195 (22.8) <0.001 
Age (median, yrs) (Q1, Q3) 13 (12,16) 14 (13,16) <0.001 
Age Categories     
     Infant, <1 yr NR NR 
<0.001 
 
     Toddler, 1-2 yr NR NR 
     Early Childhood, 3-5 yr  NR NR 
     Middle Childhood, 6-11 yr 156 (23.6) 396 (7.8) 
     Early Adolescence, 12-18 yr 473 (71.7) 4,641 (88.5) 
     Late Adolescence, >19 yr 28 (4.3) 203 (3.9) 
Race    
     Non-Hispanic White 359 (54.5) 3,320 (63.3) 
0.009 
     Black  129 (19.6) 784 (15.0) 
     Hispanic 127 (19.2) 661 (12.6) 
     Other 44 (6.7) 479 (9.1) 
Income Quartile by ZIP Code     
     1st  182 (27.5) 1,227 (23.4) 
0.16 
     2nd  157 (23.9) 1,130 (21.6) 
     3rd   148 (22.4) 1,312 (25.0) 
     4th  153 (23.2) 1,495 (28.5) 
Insurance Payer     
     Private 269 (40.8) 3,231 (61.6) 
<0.001      Government   343 (52.0) 1,680 (32.0) 
     Other 48 (7.2) 324 (6.2) 
Length of Stay: median (Q1, Q3), days 6 (5,8) 4 (3,5) <0.001 
Adjusted Hospital Charges in US $, mean (+ 
SD) 
280,576 
(182,837) 
186,084 
(98,808) 
<0.001 
Hospital Bed Size     
     Small 105 (15.9) 999 (19.1) 
0.64 
     Medium  151 (22.9) 1,015 (19.4) 
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     Large  404 (61.2) 3,229 (61.6) 
Hospital Location/Teaching Status     
     Rural  NR NR 
0.76      Urban Non-Teaching 30 (4.5) 207 (4.0) 
     Urban Teaching  628 (95.1) 5,015 (95.6) 
Hospital Region     
     Northeast  109 (16.5) 1,094 (20.9) 
0.40 
     Midwest or North Central  161 (24.4) 1,193 (22.7) 
     South  220 (33.3) 1,892 (36.1) 
     West  170 (25.8) 1,065 (20.3) 
Note: weighted data 
NR = Not Reported in compliance with the HCUP data use agreement   
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Table 2: Frequency of Complications of Children with CP vs. IS undergoing Spinal Fusion  
Table 2. Morbidity of Children with CP vs. IS undergoing Spinal Fusion  
 CP 
n(%) 
IS 
n(%) 
P-value  
Morbidity    
Any Complication  288 (43.6) 1,111 (21.2) <0.001 
     Pulmonary  68 (10.4) 50 (1.0) <0.001 
     Gastrointestinal  38 (5.8) 75 (1.4) <0.001 
     Surgical  18 (2.8) 26 (0.5) <0.001 
     Blood Transfusion  200 (30.4) 979 (18.7) 0.002 
Number of Complications     
     None 372 (56.4) 4,133 (78.8) <0.001 
     One  217 (32.9) 1,058 (20.2) 0.002 
     Two or More 71 (10.7) 52 (1.0) <0.001 
ICU Admission   96 (14.6) 68 (1.3) <0.001 
Note: weighted data 
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Table 3: Estimated Relative Risk of Morbidity in Children with CP vs. IS Undergoing Spinal 
Fusion     
Table 3. Estimated Relative Risk of Morbidity in Children with CP vs IS 
undergoing Spinal Fusion  
 Unadjusted Adjusted** 
 Relative Risk 95% CI  Relative Risk 95% CI 
Complications     
     Any Complication  2.06 1.61-2.62 1.73 1.26-2.36 
     Pulmonary  10.85 5.18-22.74 7.78 2.93-20.66 
     Gastrointestinal  4.06 2.19-7.51 3.26 1.53-6.96 
     Surgical  5.63 2.10-15.10 4.97 1.19-20.81 
     Blood Transfusion  1.63 1.21-2.19 1.54 1.06-2.23 
ICU Admission   11.16 4.94-25.20 6.11 2.44-15.30 
Note: weighted data  
**Adjusted for age (continuous), race, gender, insurance payer, gastroesophageal reflux disease, 
failure to thrive, presence of a gastrostomy tube, presence of a tracheostomy, and nutritional 
deficiency   
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Figures  
Figure 1: Map of U.S. States by U.S. Census Bureau Regions  
 
2016 Introduction to the KID. Healthcare Cost and Utilization Project (HCUP). September 2018. Agency for Healthcare Research and 
Quality, Rockville, MD. www.hcup-us.ahrq.gov/db/nation/kid/kid_2016_introduction.jsp 
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Appendix 
Appendix A: List of ICD-10 Codes Spinal Fusion Surgery  
ICD-10 
Procedure 
Codes 
Description  
0RG7071 Fusion of 2 to 7 Thoracic Vertebral Joints with Autologous Tissue Substitute, 
Posterior Approach, Posterior Column, Open Approach 
0RG707J Fusion of 2 to 7 Thoracic Vertebral Joints with Autologous Tissue Substitute, 
Posterior Approach, Anterior Column, Open Approach 
0RG70AJ Fusion of 2 to 7 Thoracic Vertebral Joints with Interbody Fusion Device, Posterior 
Approach, Anterior Column, Open Approach 
0RG70J1 Fusion of 2 to 7 Thoracic Vertebral Joints with Synthetic Substitute, Posterior 
Approach, Posterior Column, Open Approach 
0RG70JJ Fusion of 2 to 7 Thoracic Vertebral Joints with Synthetic Substitute, Posterior 
Approach, Anterior Column, Open Approach 
0RG70K1 Fusion of 2 to 7 Thoracic Vertebral Joints with Nonautologous Tissue Substitute, 
Posterior Approach, Posterior Column, Open Approach 
0RG70KJ Fusion of 2 to 7 Thoracic Vertebral Joints with Nonautologous Tissue Substitute, 
Posterior Approach, Anterior Column, Open Approach 
0RG7371 Fusion of 2 to 7 Thoracic Vertebral Joints with Autologous Tissue Substitute, 
Posterior Approach, Posterior Column, Percutaneous Approach 
0RG737J  Fusion of 2 to 7 Thoracic Vertebral Joints with Autologous Tissue Substitute, 
Posterior Approach, Anterior Column, Percutaneous Approach 
0RG73AJ Fusion of 2 to 7 Thoracic Vertebral Joints with Interbody Fusion Device, Posterior 
Approach, Anterior Column, Percutaneous Approach 
0RG73J1 Fusion of 2 to 7 Thoracic Vertebral Joints with Synthetic Substitute, Posterior 
Approach, Posterior Column, Percutaneous Approach 
0RG73JJ Fusion of 2 to 7 Thoracic Vertebral Joints with Synthetic Substitute, Posterior 
Approach, Anterior Column, Percutaneous Approach 
0RG73K1 Fusion of 2 to 7 Thoracic Vertebral Joints with Nonautologous Tissue Substitute, 
Posterior Approach, Posterior Column, Percutaneous Approach 
0RG73KJ Fusion of 2 to 7 Thoracic Vertebral Joints with Nonautologous Tissue Substitute, 
Posterior Approach, Anterior Column, Percutaneous Approach 
0RG7471 Fusion of 2 to 7 Thoracic Vertebral Joints with Autologous Tissue Substitute, 
Posterior Approach, Posterior Column, Percutaneous Endoscopic Approach 
0RG747J Fusion of 2 to 7 Thoracic Vertebral Joints with Autologous Tissue Substitute, 
Posterior Approach, Anterior Column, Percutaneous Endoscopic Approach 
0RG74AJ Fusion of 2 to 7 Thoracic Vertebral Joints with Interbody Fusion Device, Posterior 
Approach, Anterior Column, Percutaneous Endoscopic Approach 
0RG74J1 Fusion of 2 to 7 Thoracic Vertebral Joints with Synthetic Substitute, Posterior 
Approach, Posterior Column, Percutaneous Endoscopic Approach 
0RG74JJ Fusion of 2 to 7 Thoracic Vertebral Joints with Synthetic Substitute, Posterior 
Approach, Anterior Column, Percutaneous Endoscopic Approach 
0RG74K1 Fusion of 2 to 7 Thoracic Vertebral Joints with Nonautologous Tissue Substitute, 
Posterior Approach, Posterior Column, Percutaneous Endoscopic Approach 
33 
0RG74KJ Fusion of 2 to 7 Thoracic Vertebral Joints with Nonautologous Tissue Substitute, 
Posterior Approach, Anterior Column, Percutaneous Endoscopic Approach 
0RG8071 Fusion of 8 or more Thoracic Vertebral Joints with Autologous Tissue Substitute, 
Posterior Approach, Posterior Column, Open Approach 
0RG807J Fusion of 8 or more Thoracic Vertebral Joints with Autologous Tissue Substitute, 
Posterior Approach, Anterior Column, Open Approach 
0RG80AJ Fusion of 8 or more Thoracic Vertebral Joints with Interbody Fusion Device, 
Posterior Approach, Anterior Column, Open Approach 
0RG80J1 Fusion of 8 or more Thoracic Vertebral Joints with Synthetic Substitute, Posterior 
Approach, Posterior Column, Open Approach 
0RG80JJ Fusion of 8 or more Thoracic Vertebral Joints with Synthetic Substitute, Posterior 
Approach, Anterior Column, Open Approach 
0RG80K1 Fusion of 8 or more Thoracic Vertebral Joints with Nonautologous Tissue 
Substitute, Posterior Approach, Posterior Column, Open Approach 
0RG80KJ Fusion of 8 or more Thoracic Vertebral Joints with Nonautologous Tissue 
Substitute, Posterior Approach, Anterior Column, Open Approach 
0RG8371 Fusion of 8 or more Thoracic Vertebral Joints with Autologous Tissue Substitute, 
Posterior Approach, Posterior Column, Percutaneous Approach 
0RG837J Fusion of 8 or more Thoracic Vertebral Joints with Autologous Tissue Substitute, 
Posterior Approach, Anterior Column, Percutaneous Approach 
0RG83AJ Fusion of 8 or more Thoracic Vertebral Joints with Interbody Fusion Device, 
Posterior Approach, Anterior Column, Percutaneous Approach 
0RG83J1 Fusion of 8 or more Thoracic Vertebral Joints with Synthetic Substitute, Posterior 
Approach, Posterior Column, Percutaneous Approach 
0RG83JJ Fusion of 8 or more Thoracic Vertebral Joints with Synthetic Substitute, Posterior 
Approach, Anterior Column, Percutaneous Approach 
0RG83K1 Fusion of 8 or more Thoracic Vertebral Joints with Nonautologous Tissue 
Substitute, Posterior Approach, Posterior Column, Percutaneous Approach 
0RG83KJ Fusion of 8 or more Thoracic Vertebral Joints with Nonautologous Tissue 
Substitute, Posterior Approach, Anterior Column, Percutaneous Approach 
0RG8471 Fusion of 8 or more Thoracic Vertebral Joints with Autologous Tissue Substitute, 
Posterior Approach, Posterior Column, Percutaneous Endoscopic Approach 
0RG847J Fusion of 8 or more Thoracic Vertebral Joints with Autologous Tissue Substitute, 
Posterior Approach, Anterior Column, Percutaneous Endoscopic Approach 
0RG84AJ Fusion of 8 or more Thoracic Vertebral Joints with Interbody Fusion Device, 
Posterior Approach, Anterior Column, Percutaneous Endoscopic Approach 
0RG84J1 Fusion of 8 or more Thoracic Vertebral Joints with Synthetic Substitute, Posterior 
Approach, Posterior Column, Percutaneous Endoscopic Approach 
0RG84JJ Fusion of 8 or more Thoracic Vertebral Joints with Synthetic Substitute, Posterior 
Approach, Anterior Column, Percutaneous Endoscopic Approach 
0RG84K1 Fusion of 8 or more Thoracic Vertebral Joints with Nonautologous Tissue 
Substitute, Posterior Approach, Posterior Column, Percutaneous Endoscopic 
Approach 
0RG84KJ Fusion of 8 or more Thoracic Vertebral Joints with Nonautologous Tissue 
Substitute, Posterior Approach, Anterior Column, Percutaneous Endoscopic 
Approach 
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0RGA071 Fusion of Thoracolumbar Vertebral Joint with Autologous Tissue Substitute, 
Posterior Approach, Posterior Column, Open Approach 
0RGA07J Fusion of Thoracolumbar Vertebral Joint with Autologous Tissue Substitute, 
Posterior Approach, Anterior Column, Open Approach 
0RGA0AJ Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Posterior 
Approach, Anterior Column, Open Approach 
0RGA0J1 Fusion of Thoracolumbar Vertebral Joint with Synthetic Substitute, Posterior 
Approach, Posterior Column, Open Approach 
0RGA0JJ Fusion of Thoracolumbar Vertebral Joint with Synthetic Substitute, Posterior 
Approach, Anterior Column, Open Approach 
0RGA0K1 Fusion of Thoracolumbar Vertebral Joint with Nonautologous Tissue Substitute, 
Posterior Approach, Posterior Column, Open Approach 
0RGA0KJ Fusion of Thoracolumbar Vertebral Joint with Nonautologous Tissue Substitute, 
Posterior Approach, Anterior Column, Open Approach 
0RGA371  Fusion of Thoracolumbar Vertebral Joint with Autologous Tissue Substitute, 
Posterior Approach, Posterior Column, Percutaneous Approach 
0RGA37J Fusion of Thoracolumbar Vertebral Joint with Autologous Tissue Substitute, 
Posterior Approach, Anterior Column, Percutaneous Approach 
0RGA3AJ Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Posterior 
Approach, Anterior Column, Percutaneous Approach 
0RGA3J1 Fusion of Thoracolumbar Vertebral Joint with Synthetic Substitute, Posterior 
Approach, Posterior Column, Percutaneous Approach 
0RGA3JJ Fusion of Thoracolumbar Vertebral Joint with Synthetic Substitute, Posterior 
Approach, Anterior Column, Percutaneous Approach 
0RGA3K1 Fusion of Thoracolumbar Vertebral Joint with Nonautologous Tissue Substitute, 
Posterior Approach, Posterior Column, Percutaneous Approach 
0RGA3KJ Fusion of Thoracolumbar Vertebral Joint with Nonautologous Tissue Substitute, 
Posterior Approach, Anterior Column, Percutaneous Approach 
0RGA471 Fusion of Thoracolumbar Vertebral Joint with Autologous Tissue Substitute, 
Posterior Approach, Posterior Column, Percutaneous Endoscopic Approach 
0RGA47J Fusion of Thoracolumbar Vertebral Joint with Autologous Tissue Substitute, 
Posterior Approach, Anterior Column, Percutaneous Endoscopic Approach 
0RG64AJ Fusion of Thoracolumbar Vertebral Joint with Interbody Fusion Device, Posterior 
Approach, Anterior Column, Percutaneous Endoscopic Approach 
0RG64J1 Fusion of Thoracolumbar Vertebral Joint with Synthetic Substitute, Posterior 
Approach, Posterior Column, Percutaneous Endoscopic Approach 
0RG64JJ Fusion of Thoracolumbar Vertebral Joint with Synthetic Substitute, Posterior 
Approach, Anterior Column, Percutaneous Endoscopic Approach 
0RGA4K1 Fusion of Thoracolumbar Vertebral Joint with Nonautologous Tissue Substitute, 
Posterior Approach, Posterior Column, Percutaneous Endoscopic Approach 
0RGA4KJ Fusion of Thoracolumbar Vertebral Joint with Nonautologous Tissue Substitute, 
Posterior Approach, Anterior Column, Percutaneous Endoscopic Approach 
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Appendix B: List of ICD-10 Codes Used for Complications  
ICD-10 
Diagnosis/Procedure Codes  
Description  
Mechanical Wound   
     T8130XA Disruption of wound, unspecified, initial encounter  
     T8131XA Disruption of external operation (surgical) wound, not 
elsewhere classified, initial encounter 
     T8132XA  Disruption of internal operation (surgical) wound, not 
elsewhere classified, initial encounter  
     T8133XA Disruption of traumatic injury wound repair, initial encounter 
Infectious   
     A40.0- A40.9 Streptococcal sepsis  
     A41.0-A41.9 Other sepsis  
     T81.12XA Postprocedural septic shock, initial encounter 
     T81.40XA Infection following a procedure, unspecified, initial encounter  
     T81.41XA Infection following a procedure, superficial incisional surgical 
site, initial encounter  
     T81.42XA Infection following a procedure, deep incisional surgical site, 
initial encounter  
     T81.43XA Infection following a procedure, organ and space surgical site, 
initial encounter  
     T81.44XA Sepsis following a procedure, initial encounter  
     T81.49XA Infection following a procedure, other surgical site, initial 
encounter 
Urinary  
     N99.89 Other postprocedural complications and disorders of 
genitourinary system 
Pulmonary  
     J95.1 Acute pulmonary insufficiency following thoracic surgery 
     J95.2 Acute pulmonary insufficiency following nonthoracic surgery 
     J95.811 Postprocedural pneumothorax 
     J95.812 Postprocedural air leak 
     J95.821 Acute postprocedural respiratory failure 
     J95.822 Acute and chronic postprocedural respiratory failure 
     J95.860 Postprocedural hematoma of a respiratory system organ or 
structure following a respiratory system procedure 
     J95.861 Postprocedural hematoma of a respiratory system organ or 
structure following other procedure 
     J95.862 Postprocedural seroma of a respiratory system organ or 
structure following a respiratory system procedure 
     J95.863 Postprocedural seroma of a respiratory system organ or 
structure following other procedure 
Gastrointestinal   
     K56.0 Paralytic ileus  
     K56.7 Ileus, unspecified  
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     K91.30- K91.32 Postprocedural intestinal obstruction  
Cardiovascular  
     I82.601-I82.609 Acute embolism and thrombosis of veins of upper extremity 
     I82.611-I82.619 Acute embolism and thrombosis of superficial veins of upper 
extremity 
     I82.621- I82.629 Acute embolism and thrombosis of deep veins of upper 
extremity 
     I82.811- I82.819 Embolism and thrombosis of other specified veins 
     I82.890 Acute embolism and thrombosis of other specified veins 
     I82.A11- I82.A19 Acute embolism and thrombosis of axillary vein 
     I82.B11-I82.B19 Acute embolism and thrombosis of subclavian vein 
     I82.C11- I82.C19 Acute embolism and thrombosis of internal jugular vein 
     T81.10XA Postprocedural shock unspecified, initial encounter  
     T81.11XA Postprocedural cardiogenic shock, initial encounter  
     T81.19XA Other postprocedural shock, initial encounter  
Decubitus Ulcer  
     L89.000- L89.029 Pressure ulcer of elbow 
     L89.100- L89.149 Pressure ulcer of back 
     L89.150- L89.159 Pressure ulcer of sacral region 
     L89.200- L89.229 Pressure ulcer of hip 
     L89.300-L89.329 Pressure ulcer of buttock 
     L89.40-L89.46 Pressure ulcer of contiguous site of back, buttock and hip 
     L89.500-L89.529 Pressure ulcer of ankle 
     L89.600- L89.629 Pressure ulcer of heel 
     L89.810- L89.899 Pressure ulcer of other site  
     L89.90- L89.96 Pressure ulcer of unspecified site  
Foreign Body   
     T81.500A Unspecified complication of foreign body accidentally left in 
body following surgical operation, initial encounter 
     T81.504A Unspecified complication of foreign body accidentally left in 
body following endoscopic examination, initial encounter  
     T81.506A Unspecified complication of foreign body accidentally left in 
body following aspiration, puncture or other catheterization, 
initial encounter 
     T81.507A Unspecified complication of foreign body accidentally left in 
body following removal of catheter or packing, initial encounter  
     T81.508A  Unspecified complication of foreign body accidentally left in 
body following other procedure, initial encounter  
     T81.509A Unspecified complication of foreign body accidentally left in 
body following unspecified procedure, initial encounter  
     T81.510A Adhesions due to foreign body accidentally left in body 
following surgical operation, initial encounter  
     T81.511A Adhesions due to foreign body accidentally left in body 
following infusion or transfusion, initial encounter  
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     T81.514A Adhesions due to foreign body accidentally left in body 
following endoscopic examination, initial encounter  
     T81.516A Adhesions due to foreign body accidentally left in body 
following aspiration, puncture or other catheterization, initial 
encounter  
     T81.517A Adhesions due to foreign body accidentally left in body 
following removal of catheter or packing, initial encounter  
     T81.518A Adhesions due to foreign body accidentally left in body 
following other procedure, initial encounter  
     T81.519A Adhesions due to foreign body accidentally left in body 
following unspecified procedure, initial encounter  
     T81.520A Obstruction due to foreign body accidentally left in body 
following surgical operation, initial encounter  
     T81.521A Obstruction due to foreign body accidentally left in body 
following infusion or transfusion, initial encounter  
     T81.524A Obstruction due to foreign body accidentally left in body 
following endoscopic examination, initial encounter  
     T81.526A Obstruction due to foreign body accidentally left in body 
following aspiration, puncture or other catheterization, initial 
encounter 
     T81.527A Obstruction due to foreign body accidentally left in body 
following removal of catheter or packing, initial encounter  
     T81.528A Obstruction due to foreign body accidentally left in body 
following other procedure, initial encounter  
     T81.529A Obstruction due to foreign body accidentally left in body 
following unspecified procedure, initial encounter  
     T81.590A Other complications of foreign body accidentally left in body 
following surgical operation, initial encounter  
     T81.591A Other complications of foreign body accidentally left in body 
following infusion or transfusion, initial encounter  
     T81.594A Other complications of foreign body accidentally left in body 
following endoscopic examination, initial encounter  
     T81.596A Other complications of foreign body accidentally left in body 
following aspiration, puncture or other catheterization, initial 
encounter 
     T81.597A Other complications of foreign body accidentally left in body 
following removal of catheter or packing, initial encounter  
     T81.598A Other complications of foreign body accidentally left in body 
following other procedure, initial encounter  
     T81.599A Other complications of foreign body accidentally left in body 
following unspecified procedure, initial encounter  
     T81.60XA Unspecified acute reaction to foreign substance accidentally left 
during a procedure, initial encounter 
     T81.61XA Aseptic peritonitis due to foreign substance accidentally left 
during a procedure, initial encounter  
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     T81.69XA Other acute reaction to foreign substance accidentally left 
during a procedure, initial encounter  
Central Venous Catheter  
     T800XXA Air embolism following infusion, transfusion and therapeutic 
injection, initial encounter  
     T801XXA Vascular complications following infusion, transfusion and 
therapeutic injection, initial encounter  
     T80211A Bloodstream infection due to central venous catheter, initial 
encounter 
     T8029XA Infection following other infusion, transfusion and therapeutic 
injection, initial encounter  
Surgical   
     G97.32 Intraoperative hemorrhage and hematoma of a nervous system 
organ or structure complicating other procedure 
     G97.41 Accidental puncture or laceration of dura during a procedure 
     G97.49 Accidental puncture and laceration of other nervous system 
organ or structure during other procedure 
     G97.81 Other intraoperative complications of nervous system 
     I97.42 Intraoperative hemorrhage and hematoma of a circulatory 
system organ or structure complicating other procedure 
     I97.52 Accidental puncture and laceration of a circulatory system 
organ or structure during other procedure 
     I97.711 Intraoperative cardiac arrest during other surgery  
     I97.791 Other intraoperative cardiac functional disturbances during 
other surgery 
     I97.811 Intraoperative cerebrovascular infarction during other surgery  
     I97.88 Other intraoperative complications of the circulatory system, 
not elsewhere classified 
     J95.62  Intraoperative hemorrhage and hematoma of a respiratory 
system organ or structure complicating other procedure 
     J95.72 Accidental puncture and laceration of a respiratory system 
organ or structure during other procedure 
     J95.88 Other intraoperative complications of respiratory system, not 
elsewhere classified 
     K91.62 Intraoperative hemorrhage and hematoma of a digestive system 
organ or structure complicating other procedure 
     K91.72 Accidental puncture and laceration of a digestive system organ 
or structure during other procedure 
     K91.81 Other intraoperative complications of digestive system 
     L76.02 Intraoperative hemorrhage and hematoma of skin and 
subcutaneous tissue complicating other procedure 
     L76.12 Accidental puncture and laceration of skin and subcutaneous 
tissue during other procedure 
     L76.22 Postprocedural hemorrhage of skin and subcutaneous tissue 
following other procedure 
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     L76.32 Postprocedural hematoma of skin and subcutaneous tissue 
following other procedure 
     L76.81  Other intraoperative complications of skin and subcutaneous 
tissue 
     M96.810 Intraoperative hemorrhage and hematoma of a musculoskeletal 
structure complicating a musculoskeletal system procedure 
     M96.811 Intraoperative hemorrhage and hematoma of a musculoskeletal 
structure complicating other procedure 
     M96.820 Accidental puncture and laceration of a musculoskeletal 
structure during a musculoskeletal system procedure 
     M96.821 Accidental puncture and laceration of a musculoskeletal 
structure during other procedure 
     M96.89 Other intraoperative and postprocedural complications and 
disorders of the musculoskeletal system 
     N99.62 Intraoperative hemorrhage and hematoma of a genitourinary 
system organ or structure complicating other procedure 
     N99.72 Accidental puncture and laceration of a genitourinary system 
organ or structure during other procedure 
     N99.81 Other intraoperative complications of genitourinary system 
Blood Transfusion  
     3023AZ- 30233Y4 Transfusion of blood products into peripheral vein 
     30240AZ-30243Y4 Transfusion of blood products into central vein  
     30280B1- 30283B1 Transfusion of Non-autologous 4-Factor Prothrombin Complex 
Concentrate into Vein 
Venous Thromboembolism 
(Lower Extremity) 
 
     I82.401-I82.409 Acute embolism and thrombosis of unspecified deep veins of 
lower extremity 
     I82.411-I82.419 Acute embolism and thrombosis of femoral vein 
     I82.421-I82.429 Acute embolism and thrombosis of iliac vein 
     I82.431-I82.439 Acute embolism and thrombosis of popliteal vein 
     I82.441-I82.449 Acute embolism and thrombosis of tibial vein 
     I82.491-I82.499 Acute embolism and thrombosis of other specified deep vein of 
lower extremity 
     I82.4Y1-I82.4Y9 Acute embolism and thrombosis of unspecified deep veins of 
proximal lower extremity 
     I82.4Z1-I82.4Z9 Acute embolism and thrombosis of unspecified deep veins of 
distal lower extremity 
Arterial Line  
     4A130B1 Monitoring of Arterial Pressure, Peripheral, Open Approach 
     4A133B1 Monitoring of Arterial Pressure, Peripheral, Percutaneous 
Approach 
Ventilator Use  
     5A1935Z Respiratory Ventilation, Less than 24 Consecutive Hours 
     5A1945Z Respiratory Ventilation, 24-96 Consecutive Hours 
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     5A1955Z Respiratory Ventilation, Greater than 96 Consecutive Hours 
Internal Jugular Central Line  
     05HN03Z Insertion of Infusion Device into Left Internal Jugular Vein, 
Open Approach 
     05HN0DZ Insertion of Intraluminal Device into Left Internal Jugular Vein, 
Open Approach 
     05HN33Z Insertion of Infusion Device into Left Internal Jugular Vein, 
Percutaneous Approach 
     05HN3DZ Insertion of Intraluminal Device into Left Internal Jugular Vein, 
Percutaneous Approach 
     05HN43Z Insertion of Infusion Device into Left Internal Jugular Vein, 
Percutaneous Endoscopic Approach 
     05HN4DZ Insertion of Intraluminal Device into Left Internal Jugular Vein, 
Percutaneous Endoscopic Approach 
     05HM03Z  Insertion of Infusion Device into Right Internal Jugular Vein, 
Open Approach 
     05HM0DZ Insertion of Intraluminal Device into Right Internal Jugular 
Vein, Open Approach 
     05HM33Z Insertion of Infusion Device into Right Internal Jugular Vein, 
Percutaneous Approach 
     05HM3DZ  Insertion of Intraluminal Device into Right Internal Jugular 
Vein, Percutaneous Approach 
     05HM43Z Insertion of Infusion Device into Right Internal Jugular Vein, 
Percutaneous Endoscopic Approach 
     05HM4DZ Insertion of Intraluminal Device into Right Internal Jugular 
Vein, Percutaneous Endoscopic Approach 
Subclavian Central Line  
     05H603Z Insertion of Infusion Device into Left Subclavian Vein, Open 
Approach 
     05H60DZ Insertion of Intraluminal Device into Left Subclavian Vein, 
Open Approach 
     05H633Z Insertion of Infusion Device into Left Subclavian Vein, 
Percutaneous Approach 
     05H63DZ Insertion of Intraluminal Device into Left Subclavian Vein, 
Percutaneous Approach 
     05H643Z Insertion of Infusion Device into Left Subclavian Vein, 
Percutaneous Endoscopic Approach 
     05H64DZ Insertion of Intraluminal Device into Left Subclavian Vein, 
Percutaneous Endoscopic Approach 
     05H503Z Insertion of Infusion Device into Right Subclavian Vein, Open 
Approach 
     05H50DZ Insertion of Intraluminal Device into Right Subclavian Vein, 
Open Approach 
     05H533Z Insertion of Infusion Device into Right Subclavian Vein, 
Percutaneous Approach 
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     05H53DZ Insertion of Intraluminal Device into Right Subclavian Vein, 
Percutaneous Approach 
     05H543Z Insertion of Infusion Device into Right Subclavian Vein, 
Percutaneous Endoscopic Approach 
     05H54DZ Insertion of Intraluminal Device into Right Subclavian Vein, 
Percutaneous Endoscopic Approach 
Femoral Central Line  
     06HN03Z Insertion of Infusion Device into Left Femoral Vein, Open 
Approach 
     06HN0DZ Insertion of Intraluminal Device into Left Femoral Vein, Open 
Approach 
     06HN33Z Insertion of Infusion Device into Left Femoral Vein, 
Percutaneous Approach 
     06HN3DZ Insertion of Intraluminal Device into Left Femoral Vein, 
Percutaneous Approach 
     06HN43Z Insertion of Infusion Device into Left Femoral Vein, 
Percutaneous Endoscopic Approach 
     06HN4DZ Insertion of Intraluminal Device into Left Femoral Vein, 
Percutaneous Endoscopic Approach 
     06HM03Z Insertion of Infusion Device into Right Femoral Vein, Open 
Approach 
     06HM0DZ Insertion of Intraluminal Device into Right Femoral Vein, Open 
Approach 
     06HM33Z  Insertion of Infusion Device into Right Femoral Vein, 
Percutaneous Approach 
     06HM3DZ Insertion of Intraluminal Device into Right Femoral Vein, 
Percutaneous Approach 
     06HM43Z Insertion of Infusion Device into Right Femoral Vein, 
Percutaneous Endoscopic Approach 
     06HM4DZ Insertion of Intraluminal Device into Right Femoral Vein, 
Percutaneous Endoscopic Approach 
ECMO  
     5A1522F Extracorporeal Oxygenation, Membrane, Central 
     5A1522G Extracorporeal Oxygenation, Membrane, Peripheral Veno-
arterial 
     5A1522H Extracorporeal Oxygenation, Membrane, Peripheral Veno-
venous 
     5A05121 Extracorporeal Hyperbaric Oxygenation, Intermittent 
     5A0512C Extracorporeal Supersaturated Oxygenation, Intermittent 
     5A05221 Extracorporeal Hyperbaric Oxygenation, Continuous 
     5A0522C Extracorporeal Supersaturated Oxygenation, Continuous 
 
 
 
